Boyd Gaming Corporation (BYD)
NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 55.09 |
| Open | 56.40 |
| Bid | 54.79 x 800 |
| Ask | 58.12 x 1400 |
| Day's Range | 55.59 - 57.02 |
| 52 Week Range | 50.38 - 72.72 |
| Volume | |
| Avg. Volume | 1,168,093 |
| Market Cap | 6.341B |
| Beta (5Y Monthly) | 1.97 |
| PE Ratio (TTM) | 14.74 |
| EPS (TTM) | 3.83 |
| Earnings Date | Apr 25, 2022 - Apr 29, 2022 |
| Forward Dividend & Yield | 0.60 (1.06%) |
| Ex-Dividend Date | Mar 14, 2022 |
| 1y Target Est | 79.64 |
- Simply Wall St.
Is Now The Time To Put Boyd Gaming (NYSE:BYD) On Your Watchlist?
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
- GlobeNewswire
Cassava Sciences Reports First Quarter Financial Results for 2022 and Updates on Phase 3 Clinical Program
- $209.7 Million Cash and Cash Equivalents at March 31, 2022 – - Over 120 Patients Now Enrolled in Phase 3 Program - AUSTIN, Texas, May 05, 2022 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company focused on Alzheimer’s disease, today announced financial results for the first quarter ended March 31, 2022 and provided a clinical update on its Phase 3 clinical program of simufilam in Alzheimer’s disease. Simufilam is Cassava Sciences’ lead drug candida
- Simply Wall St.
When Should You Buy Boyd Gaming Corporation (NYSE:BYD)?
Boyd Gaming Corporation ( NYSE:BYD ), is not the largest company out there, but it received a lot of attention from a...
© 2022 Yahoo. All rights reserved.
